PureTech Health PLC (PRTC)

London
Currency in GBP
123.40
+1.00(+0.82%)
Closed·
PRTC Scorecard
Full Analysis
Holds more cash than debt on its balance sheet
Fair Value
Day's Range
121.20125.60
52 wk Range
100.40238.50
Key Statistics
Edit
Bid/Ask
121.40 / 129.00
Prev. Close
122.4
Open
123.8
Day's Range
121.2-125.6
52 wk Range
100.4-238.5
Volume
301.06K
Average Volume (3m)
609.15K
1-Year Change
-40.53%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
PRTC Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
463.68
Upside
+275.75%
Members' Sentiments
Bearish
Bullish
ProTips
Analysts anticipate sales growth in the current year
Show more

PureTech Health Company Profile

PureTech Health plc, engages in the development and commercialization of biotechnology and pharmaceutical solutions in the United States. The company is developing LYT-100, which is under Phase 2 stage, to treat idiopathic pulmonary fibrosis (IPF); and LYT-200, a IgG4 monoclonal antibody, currently under Phase 1/2 stage, targeting galectin-9 for treating solid tumors and hematological malignancies. It also develops SPT-300, an oral drug of allopregnanolone for the treatment of anxious depression; SPT-320, a novel prodrug of agomelatine for the treatment of generalized anxiety disorder; and SPT-348, a prodrug of a non-hallucinogenic neuroplastogen for the treatment of mood and other neuropsychiatric disorders. In addition, the company is developing hydrogels to enable the oral administration of peptide therapeutics in preclinical development. The company was incorporated in 2015 and is headquartered in Boston, Massachusetts.

Compare PRTC to Peers and Sector

Metrics to compare
PRTC
Peers
Sector
Relationship
P/E Ratio
−4.8x−0.5x−0.5x
PEG Ratio
0.06−0.010.00
Price/Book
1.2x1.1x2.6x
Price / LTM Sales
840.2x11.9x2.9x
Upside (Analyst Target)
275.9%285.9%57.8%
Fair Value Upside
Unlock19.2%10.2%Unlock

Analyst Ratings

2 Buy
0 Hold
0 Sell
Ratings:
2 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 463.68
(+275.75% Upside)

Earnings

Latest Release
Apr 26, 2022
EPS / Forecast
-- / -0.20
Revenue / Forecast
-- / 6.62M
EPS Revisions
Last 90 days

FAQ

What Is the PureTech Health (PRTC) Stock Price Today?

The PureTech Health stock price today is 123.40

What Stock Exchange Does PureTech Health Trade On?

PureTech Health is listed and trades on the London stock exchange.

What Is the Stock Symbol for PureTech Health?

The stock symbol for PureTech Health is "PRTC."

What Is the PureTech Health Market Cap?

As of today, PureTech Health market cap is 296.39M.

What is PureTech Health Earnings Per Share?

The PureTech Health EPS is -0.30.

From a Technical Analysis Perspective, Is PRTC a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Sell.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.